Indication
Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with official guidance.
Loading your page…
Loading your page…
Influenza, Human;Immunization;Disease Outbreaks
Marketing Authorisation Holder: GlaxoSmithKline Biologicals S.A.
EMA Authorisation: 10/10/2009
INN: pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
AI Drug & Interaction Analysis
Free account required
Ask Osler about Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals): drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.